These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11805085)

  • 1. Mapping the epitope of an inhibitory monoclonal antibody to the C-terminal DNA-binding domain of HIV-1 integrase.
    Yi J; Cheng H; Andrake MD; Dunbrack RL; Roder H; Skalka AM
    J Biol Chem; 2002 Apr; 277(14):12164-74. PubMed ID: 11805085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of inhibition of HIV-1 Integrase by a C-terminal domain-specific monoclonal antibody.
    Ramcharan J; Colleluori DM; Merkel G; Andrake MD; Skalka AM
    Retrovirology; 2006 Jun; 3():34. PubMed ID: 16790058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitory monoclonal antibody binds at the turn of the helix-turn-helix motif in the N-terminal domain of HIV-1 integrase.
    Yi J; Arthur JW; Dunbrack RL; Skalka AM
    J Biol Chem; 2000 Dec; 275(49):38739-48. PubMed ID: 10969077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping epitopes of monoclonal antibodies against HIV-1 integrase with limited proteolysis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Yi J; Skalka AM
    Biopolymers; 2000; 55(4):308-18. PubMed ID: 11169922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5'-phosphate complex reveals a new binding site for a nucleotide inhibitor.
    Williams KL; Zhang Y; Shkriabai N; Karki RG; Nicklaus MC; Kotrikadze N; Hess S; Le Grice SF; Craigie R; Pathak VK; Kvaratskhelia M
    J Biol Chem; 2005 Mar; 280(9):7949-55. PubMed ID: 15615720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants of metal-induced conformational changes in HIV-1 integrase.
    Asante-Appiah E; Seeholzer SH; Skalka AM
    J Biol Chem; 1998 Dec; 273(52):35078-87. PubMed ID: 9857042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping DNA-binding sites of HIV-1 integrase by protein footprinting.
    Dirac AM; Kjems J
    Eur J Biochem; 2001 Feb; 268(3):743-51. PubMed ID: 11168414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational aspects of HIV-1 integrase inhibition by a peptide derived from the enzyme central domain and by antibodies raised against this peptide.
    Maroun RG; Krebs D; Roshani M; Porumb H; Auclair C; Troalen F; Fermandjian S
    Eur J Biochem; 1999 Feb; 260(1):145-55. PubMed ID: 10091594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV-1 integrase α4-helix involved in LTR-DNA recognition is also a highly antigenic peptide element.
    Azzi S; Parissi V; Maroun RG; Eid P; Mauffret O; Fermandjian S
    PLoS One; 2010 Dec; 5(12):e16001. PubMed ID: 21209864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.
    Chen Z; Yan Y; Munshi S; Li Y; Zugay-Murphy J; Xu B; Witmer M; Felock P; Wolfe A; Sardana V; Emini EA; Hazuda D; Kuo LC
    J Mol Biol; 2000 Feb; 296(2):521-33. PubMed ID: 10669606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of immunogenic and protein-interacting regions at the surface of the seven-bladed beta-propeller domain of the HIV-1 cellular interactor EED.
    Rakotobe D; Violot S; Hong SS; Gouet P; Boulanger P
    Virol J; 2008 Feb; 5():32. PubMed ID: 18302803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: a three-helix bundle stabilized by zinc.
    Eijkelenboom AP; van den Ent FM; Vos A; Doreleijers JF; Hård K; Tullius TD; Plasterk RH; Kaptein R; Boelens R
    Curr Biol; 1997 Oct; 7(10):739-46. PubMed ID: 9368756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replication.
    da Silva FA; Li M; Rato S; Maia S; Malhó R; Warren K; Harrich D; Craigie R; Barbas C; Goncalves J
    Biotechnol Appl Biochem; 2012; 59(5):353-66. PubMed ID: 23586912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.
    Wang JY; Ling H; Yang W; Craigie R
    EMBO J; 2001 Dec; 20(24):7333-43. PubMed ID: 11743009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking.
    Heuer TS; Brown PO
    Biochemistry; 1997 Sep; 36(35):10655-65. PubMed ID: 9271496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies against the minimal DNA-binding domain in the carboxyl-terminal region of human immunodeficiency virus type 1 integrase.
    Ishikawa T; Okui N; Kobayashi N; Sakuma R; Kitamura T; Kitamura Y
    J Virol; 1999 May; 73(5):4475-80. PubMed ID: 10196350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.
    Molteni V; Greenwald J; Rhodes D; Hwang Y; Kwiatkowski W; Bushman FD; Siegel JS; Choe S
    Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):536-44. PubMed ID: 11264582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV integrase: a target for drug discovery.
    Lutzke RA; Plasterk RH
    Genes Funct; 1997 Dec; 1(5-6):289-307. PubMed ID: 17366700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of HIV-1 integrase.
    Chiu TK; Davies DR
    Curr Top Med Chem; 2004; 4(9):965-77. PubMed ID: 15134551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis.
    Hochleitner EO; Borchers C; Parker C; Bienstock RJ; Tomer KB
    Protein Sci; 2000 Mar; 9(3):487-96. PubMed ID: 10752610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.